Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


2019 | 1 | 67-70

Article title

The advancement of imaging in diagnosis of prostate cancer

Content

Title variants

Languages of publication

EN

Abstracts

EN
Introduction. Multiple imaging methods have been used to stage prostate carcinoma. Some of them are easily accessible, others very accurate. The advancements over many years have been taken under consideration and now every imaging method has a specific role in the diagnosis of this malignancy. Aim. There are over 1,100,000 cases of prostate carcinoma diagnosed every year around the world. Imaging examinations have to be introduced to accurately stage, and therefore properly treat this disease. This review concentrates on advantages and disadvantages of different imaging methods. Material and methods. The literature search was performed. Results. Imaging methods serve specific goals. TRUS is recommended for acquiring biopsy specimen due to high accessibilityand low cost of the examination. Conclusion. The best tool for staging prostate carcinoma and finding suspicious lesions when attempting second biopsy is mpMRI or bpMRI

Keywords

EN

Contributors

  • Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
  • Department of Photomedicine and Physical Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
  • Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
  • Department of Biochemistry and General Chemistry, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland
author
  • Department of Pathomorphology, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland

References

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.mhp-60ed1787-c1cc-4761-9337-4fd48fe793d2
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.